Eric R Olson - Net Worth and Insider Trading
Eric R Olson Net Worth
The estimated net worth of Eric R Olson is at least $16,852 dollars as of 2024-11-05. Eric R Olson is the Chief Scientific Officer of Syros Pharmaceuticals Inc and owns about 6,661 shares of Syros Pharmaceuticals Inc (SYRS) stock worth over $16,852. Details can be seen in Eric R Olson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric R Olson has not made any transactions after 2023-07-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric R Olson
Eric R Olson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric R Olson owns 1 companies in total, including Syros Pharmaceuticals Inc (SYRS) .
Click here to see the complete history of Eric R Olson’s form 4 insider trades.
Insider Ownership Summary of Eric R Olson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2023-07-17 | Chief Scientific Officer |
Eric R Olson Latest Holdings Summary
Eric R Olson currently owns a total of 1 stock. Eric R Olson owns 6,661 shares of Syros Pharmaceuticals Inc (SYRS) as of July 17, 2023, with a value of $16,852.
Latest Holdings of Eric R Olson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2023-07-17 | 6,661 | 2.53 | 16,852 |
Holding Weightings of Eric R Olson
Eric R Olson Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric R Olson has made a total of 5 transactions in Syros Pharmaceuticals Inc (SYRS) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Syros Pharmaceuticals Inc is the sale of 689 shares on July 17, 2023, which brought Eric R Olson around $2,412.
Insider Trading History of Eric R Olson
- 1
Eric R Olson Trading Performance
Eric R Olson Ownership Network
Ownership Network List of Eric R Olson
Ownership Network Relation of Eric R Olson
Eric R Olson Owned Company Details
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Eric R Olson is the Chief Scientific Officer of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Financial Officer Jason Haas , Chief Commercial Officer Chee Conley , and Chief Medical Officer David Roth .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, Eric R Olson made 1 insider transaction in Syros Pharmaceuticals Inc (SYRS) with a net sale of 689. Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net purchase of 100,000 shares made by Chee Conley .
In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 200,000 shares, with a net purchase of 200,000 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 1,073,765 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
Eric R Olson Mailing Address
Above is the net worth, insider trading, and ownership report for Eric R Olson. You might contact Eric R Olson via mailing address: C/o Syros Pharmaceuticals, Inc., 620 Memorial Drive, Suite 300, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
